Abstract

BackgroundAntimicrobial resistance poses a serious global public health threat. Hospital misuse of antibiotics has contributed to this problem and evidence-based interventions are urgently needed to change inappropriate prescribing practices. This paper reports the first theoretical stage of a longer-term project to improve antibiotic prescribing in hospitals through design of an effective behaviour-change intervention.MethodsQualitative synthesis using meta-ethnography of primary studies reporting doctors’ views and experiences of antibiotic prescribing in hospitals for example, their barriers to appropriate prescribing. Twenty electronic databases were systematically searched over a 10-year period and potential studies screened against eligibility criteria. Included studies were quality-appraised. Original participant quotes and author interpretations were extracted and coded thematically into NVivo. All study processes were conducted by two reviewers working independently with findings discussed with the wider team and key stakeholders. Studies were related by findings into clusters and translated reciprocally and refutationally to develop a new line-of-argument synthesis and conceptual model. Findings are reported using eMERGe guidance.ResultsFifteen papers (13 studies) conducted between 2007 and 2017 reporting the experiences of 336 doctors of varying seniority working in acute hospitals across seven countries, were synthesised. Study findings related in four ways which collectively represented multiple challenges to appropriate antibiotic medical prescribing in hospitals: loss of ownership of prescribing decisions, tension between individual care and public health concerns, evidence-based practice versus bedside medicine, and diverse priorities between different clinical teams. The resulting new line-of-argument and conceptual model reflected how these challenges operated on both micro- and macro-level, highlighting key areas for improving current prescribing practice, such as creating feedback mechanisms, normalising input from other specialties and reducing variation in responsibility for antibiotic decisions.ConclusionsThis first meta-ethnography of doctors` experiences of antibiotic prescribing in acute hospital settings has enabled development of a novel conceptual model enhancing understanding of appropriate antibiotic prescribing. That is, hospital antibiotic prescribing is a complex, context-dependent and dynamic process, entailing the balancing of many tensions. To change practice, comprehensive efforts are needed to manage failures in communication and information provision, promote distribution of responsibility for antibiotic decisions, and reduce fear of consequences from not prescribing.Trial registrationPROSPERO registration: CRD42017073740.

Highlights

  • Antimicrobial resistance poses a serious global public health threat

  • A recent study looking at global antibiotic consumption, expressed in defined daily doses (DDD), found that it increased by 65 % (21.1–34.8 billion DDDs) across 76 countries between 2000 and 2015 [4]

  • Most studies specified participantslevel of experience representing a range of seniority (n = 14), whilst one study focused on junior doctors [35]

Read more

Summary

Introduction

Antimicrobial resistance poses a serious global public health threat. Hospital misuse of antibiotics has contributed to this problem and evidence-based interventions are urgently needed to change inappropriate prescribing practices. This paper reports the first theoretical stage of a longer-term project to improve antibiotic prescribing in hospitals through design of an effective behaviour-change intervention. The continuing emergence and spread of antimicrobial resistance (AMR) poses a major threat to public health and patient safety due to associated morbidity, mortality and healthcare expenditure [1]. The AMR crisis has been attributed, to a significant extent, to misuse and overuse of antibiotics [2, 3]. A recent study looking at global antibiotic consumption, expressed in defined daily doses (DDD), found that it increased by 65 % (21.1–34.8 billion DDDs) across 76 countries between 2000 and 2015 [4]. A simultaneous decline in new drug development by the pharmaceutical industry due to reduced financial inducements and challenging government regulatory mechanisms has further compounded the problem [5]

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call